Triple Jeopardy for ALS Patients in Canada: The Link Between the Criteria for Diagnosis, Clinical Trials and Drug Reimbursement
April 2023Dr. Andrew DarkeALS Action Canada The diagnosis of ALS involves evaluation of Upper and Lower Motor Neurone signs and symptoms (UMN, LMN). The first diagnostic criteria were established by the World Federation of Neurology in 1994 at a conference in El Escorial, Spain. These El Escorial (EE) criteria were revised in 2000 (the Airlie […]